OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia
Jonathan M. Meyer, Christoph U. Correll
CNS Drugs (2023) Vol. 37, Iss. 7, pp. 545-570
Open Access | Times Cited: 8
Jonathan M. Meyer, Christoph U. Correll
CNS Drugs (2023) Vol. 37, Iss. 7, pp. 545-570
Open Access | Times Cited: 8
Showing 8 citing articles:
An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders
Nora Vanegas‐Arroyave, Stanley N. Caroff, Leslie Citrome, et al.
CNS Drugs (2024) Vol. 38, Iss. 4, pp. 239-254
Open Access | Times Cited: 9
Nora Vanegas‐Arroyave, Stanley N. Caroff, Leslie Citrome, et al.
CNS Drugs (2024) Vol. 38, Iss. 4, pp. 239-254
Open Access | Times Cited: 9
Anti-Inflammatory Effects of Peripheral Dopamine
Shaun C. Moore, Pedro Alves Soares Vaz de Castro, Daniel Yaqub, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13816-13816
Open Access | Times Cited: 19
Shaun C. Moore, Pedro Alves Soares Vaz de Castro, Daniel Yaqub, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13816-13816
Open Access | Times Cited: 19
Insulin Resistance/Diabetes and Schizophrenia: Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia
Chuanjun Zhuo, Qiuyu Zhang, Lina Wang, et al.
CNS Drugs (2023) Vol. 38, Iss. 1, pp. 33-44
Open Access | Times Cited: 13
Chuanjun Zhuo, Qiuyu Zhang, Lina Wang, et al.
CNS Drugs (2023) Vol. 38, Iss. 1, pp. 33-44
Open Access | Times Cited: 13
Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes
Giuseppe Lisco, Anna De Tullio, Michele Iovino, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2993-2993
Open Access | Times Cited: 11
Giuseppe Lisco, Anna De Tullio, Michele Iovino, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2993-2993
Open Access | Times Cited: 11
Prediction of treatment response in drug-naïve schizophrenia patients from the perspective of targeted metabolomics
Shuo Wang, Yeqing Dong, Yuying Qiu, et al.
Schizophrenia Research (2025) Vol. 278, pp. 9-16
Closed Access
Shuo Wang, Yeqing Dong, Yuying Qiu, et al.
Schizophrenia Research (2025) Vol. 278, pp. 9-16
Closed Access
Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies—A Narrative Review
Tudor-Florentin Capatina, Anamaria Oatu, Casandra Babasan, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4285-4285
Open Access
Tudor-Florentin Capatina, Anamaria Oatu, Casandra Babasan, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4285-4285
Open Access
Los receptores muscarínicos como potencial objetivo terapéutico en la esquizofrenia
José Eduardo López Villa
eNeurobiología (2024) Vol. 15, Iss. 38
Open Access | Times Cited: 1
José Eduardo López Villa
eNeurobiología (2024) Vol. 15, Iss. 38
Open Access | Times Cited: 1
Efficacy and safety of Xiaoyao Pill combined with Western medicine in the treatment of schizophrenia: A Meta-analysis and Systematic review
Lili Cai, Lianqi Liu, Zhibing Jiang, et al.
Medicine (2024) Vol. 103, Iss. 10, pp. e37226-e37226
Open Access
Lili Cai, Lianqi Liu, Zhibing Jiang, et al.
Medicine (2024) Vol. 103, Iss. 10, pp. e37226-e37226
Open Access
